Clinical implications of anti-thyroglobulin antibody measurement before surgery in thyroid cancer

키워드

참고문헌 (54)

1. Hegedus L., "Clinical practice: the thyroid nodule", N Engl J Med, 351, pp.1764~1771 (2004)
2. Hori M, "Morphological distribution of thyroid cancer from Cancer Incidence in Five Continents Vol. X", Jpn J Clin Oncol, 45, pp.1182~ (2015)
3. Cho BY, "Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades", Thyroid, 23, pp.797~804 (2013)
4. Haugen BR, "2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer", Thyroid, 26, pp.1~133 (2016)
5. Bayer MF, "Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera", J Clin Endocrinol Metab, 49, pp.557~564 (1979)
6. Schneider AB, "Radioimmunoassay of human thyroglobulin: effect of antithyroglobulin autoantibodies", J Clin Endocrinol Metab, 47, pp.126~137 (1978)
7. Fröhlich E, "Thyroid autoimmunity: role of anti-thyroid antibodies in thyroid and extra-thyroidal diseases", Front Immunol, 8, pp.521~ (2017)
8. Roitt IM, "Auto-antibodies in Hashimoto's disease (lymphadenoid goitre)", Lancet, 271, pp.820~821 (1956)
9. Rose NR, "Studies on organ specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extracts", J Immunol, 76, pp.417~427 (1956)
10. Barin JG, "Iodination of murine thyroglobulin enhances autoimmune reactivity in the NOD.H2 mouse", Clin Exp Immunol, 142, pp.251~259 (2005)
11. Li Y, "Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes", J Clin Endocrinol Metab, 93, pp.1751~1757 (2008)
12. Latrofa F, "Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies", J Clin Endocrinol Metab, 93, pp.591~596 (2008)
13. Caturegli P, "IgG subclass distribution of thyroglobulin antibodies in patients with thyroid disease", Clin Exp Immunol, 98, pp.464~469 (1994)
14. Spencer CA, "Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma", J Clin Endocrinol Metab, 83, pp.1121~1127 (1998)
15. Feldt-Rasmussen U, "Autoimmunity in differentiated thyroid cancer: significance and related clinical problems", Hormones (Athens), 9, pp.109~117 (2010)
16. Kebebew E, "Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited", World J Surg, 25, pp.632~637 (2001)
17. Kim ES, "Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules", Thyroid, 20, pp.885~891 (2010)
18. Braverman LE, "Werner & Ingbar’s the Thyroid: A Fundamental and Clinical Text" (2013), Lippincott Williams & Wilkins
19. McLachlan SM, "Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies?", Thyroid, 14, pp.510~520 (2004)
20. Vasileiadis I, "Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma", Ann Surg Oncol, 21, pp.2725~2732 (2014)
21. Grani G, "Thyroid autoimmunity and risk of malignancy in thyroid nodules submitted to fine-needle aspiration cytology", Head Neck, 37, pp.260~264 (2015)
22. Hosseini S, "Can preoperative thyroglobulin antibody levels be used as a marker for well differentiated thyroid cancer?", J Otolaryngol Head Neck Surg, 45, pp.31~ (2016)
23. Qin J, "High thyroglobulin antibody levels increase the risk of differentiated thyroid carcinoma", Dis Markers, 2015, pp.648670~ (2015)
24. Anil C, "Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study", Thyroid, 20, pp.601~606 (2010)
25. Rago T, "Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy", Clin Endocrinol (Oxf ), 67, pp.363~369 (2007)
26. Lun Y, "Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis", Otolaryngol Head Neck Surg, 148, pp.396~402 (2013)
27. Wu X, "Coexistence of thyroglobulin antibodies and thyroid peroxidase antibodies correlates with elevated thyroid-stimulating hormone level and advanced tumor stage of papillary thyroid cancer", Endocrine, 46, pp.554~560 (2014)
28. Castagna MG, "Nodules in autoimmune thyroiditis are associated with increased risk of thyroid cancer in surgical series but not in cytological series: evidence for selection bias", J Clin Endocrinol Metab, 99, pp.3193~3198 (2014)
29. Hadjisavva IS, "Prevalence of cancer in patients with thyroid nodules in the island of cyprus: predictive value of ultrasound features and thyroid autoimmune status", Eur Thyroid J, 4, pp.123~128 (2015)
30. Selek A, "Thyroid autoimmunity: is really associated with papillary thyroid carcinoma?", Eur Arch Otorhinolaryngol, 274, pp.1677~1681 (2017)
31. Kim EY, "Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma", Clin Endocrinol (Oxf ), 71, pp.581~586 (2009)
32. Durante C, "Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodies", Thyroid, 24, pp.1139~1145 (2014)
33. McLeod DS, "Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis", Thyroid, 24, pp.35~42 (2014)
34. Jo K, "Prognostic value of preoperative anti-thyroglobulin antibody in differentiated thyroid cancer", Clin Endocrinol (Oxf ), 87, pp.292~299 (2017)
35. Zhang T, "Effect of lymph node metastasis on change of positive thyroglobulin antibody in differentiated thyroid carcinoma after initial treatment", Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 39, pp.539~543 (2017)
36. Li W, "The relationship between BRAFV600E, NF-κB and TgAb expression in papillary thyroid carcinoma", Pathol Res Pract, 213, pp.183~188 (2017)
37. Nishikawa M, "Induction of tumorspecific immune response by gene transfer of Hsp70-cell-penetrating peptide fusion protein to tumors in mice", Mol Ther, 18, pp.421~428 (2010)
38. Boon T, "From defined human tumor antigens to effective immunization?", Immunol Today, 16, pp.334~336 (1995)
39. Siraj AK, "Genomic profiling of thyroid cancer reveals a role for thyroglobulin in metastasis", Am J Hum Genet, 98, pp.1170~1180 (2016)
40. Gorges R, "Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3years after thyroidectomy", Eur J Endocrinol, 153, pp.49~55 (2005)
41. Chiovato L, "Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens", Ann Intern Med, 139(5 Pt 1), pp.346~351 (2003)
42. Hsieh CJ, "Sequential changes of serum antithyroglobulin antibody levels are a good predictor of disease activity in thyroglobulin-negative patients with papillary thyroid carcinoma", Thyroid, 24, pp.488~493 (2014)
43. Kim WG, "Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma", J Clin Endocrinol Metab, 93, pp.4683~4689 (2008)
44. 임동준, "Clinical Significance of Observation without Repeated Radioiodine Therapy in Differentiated Thyroid Carcinoma Patients with Positive Surveillance Whole-Body Scans and Negative Thyroglobulin", The Korean Journal of Internal Medicine, 25(4), pp.408~414 (2010), 대한내과학회
45. Dewi AR, "Antithyroglobulin antibody as a marker of successful ablation therapy in differentiated thyroid cancer", World J Nucl Med, 16, pp.15~20 (2017)
46. Trimboli P, "Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome", Clin Chem Lab Med, 55, pp.1995~2001 (2017)
47. Snozek CL, "Serum thyroglobulin, high-resolution ultrasound, and lymph node thyroglobulin in diagnosis of differentiated thyroid carcinoma nodal metastases", J Clin Endocrinol Metab, 92, pp.4278~4281 (2007)
48. Shin HJ, "A study on serum antithyroglobulin antibodies interference in thyroglobulin measurement in fine-needle aspiration for diagnosing lymph node metastasis in postoperative patients", PLoS One, 10, pp.e0131096~ (2015)
49. Jeon MJ, "Serum antithyroglobulin antibodies interfere with thyroglobulin detection in fine-needle aspirates of metastatic neck nodes in papillary thyroid carcinoma", J Clin Endocrinol Metab, 98, pp.153~160 (2013)
50. Fiore E, "Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer", J Endocrinol Invest, 30, pp.734~738 (2007)
51. Jo K, "Lowered cutoff of lymph node fine-needle aspiration thyroglobulin in thyroid cancer patients with serum anti-thyroglobulin antibody", Eur J Endocrinol, 173, pp.489~497 (2015)
52. Baskin HJ, "Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes", Thyroid, 14, pp.959~963 (2004)
53. Boi F, "The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies", J Clin Endocrinol Metab, 91, pp.1364~1369 (2006)
54. Duval M, "Impact of serum tsh and anti-thyroglobulin antibody levels on lymph node fine-needle aspiration thyroglobulin measurements in differentiated thyroid cancer patients", Eur Thyroid J, 6, pp.292~297 (2017)

관련 논문AI추천